230 related articles for article (PubMed ID: 24133210)
1. Effects of isoform-selective phosphatidylinositol 3-kinase inhibitors on osteoclasts: actions on cytoskeletal organization, survival, and resorption.
Shugg RP; Thomson A; Tanabe N; Kashishian A; Steiner BH; Puri KD; Pereverzev A; Lannutti BJ; Jirik FR; Dixon SJ; Sims SM
J Biol Chem; 2013 Dec; 288(49):35346-57. PubMed ID: 24133210
[TBL] [Abstract][Full Text] [Related]
2. Selective role of PI3K delta in neutrophil inflammatory responses.
Sadhu C; Dick K; Tino WT; Staunton DE
Biochem Biophys Res Commun; 2003 Sep; 308(4):764-9. PubMed ID: 12927784
[TBL] [Abstract][Full Text] [Related]
3. Loss of Cbl-PI3K interaction enhances osteoclast survival due to p21-Ras mediated PI3K activation independent of Cbl-b.
Adapala NS; Barbe MF; Tsygankov AY; Lorenzo JA; Sanjay A
J Cell Biochem; 2014 Jul; 115(7):1277-89. PubMed ID: 24470255
[TBL] [Abstract][Full Text] [Related]
4. Regulation of osteoclast apoptosis and motility by small GTPase binding protein Rac1.
Fukuda A; Hikita A; Wakeyama H; Akiyama T; Oda H; Nakamura K; Tanaka S
J Bone Miner Res; 2005 Dec; 20(12):2245-53. PubMed ID: 16294277
[TBL] [Abstract][Full Text] [Related]
5. The p110delta isoform of PI3K differentially regulates beta1 and beta2 integrin-mediated monocyte adhesion and spreading and modulates diapedesis.
Ferreira AM; Isaacs H; Hayflick JS; Rogers KA; Sandig M
Microcirculation; 2006 Sep; 13(6):439-56. PubMed ID: 16864411
[TBL] [Abstract][Full Text] [Related]
6. Wortmannin inhibits spreading and chemotaxis of rat osteoclasts in vitro.
Pilkington MF; Sims SM; Dixon SJ
J Bone Miner Res; 1998 Apr; 13(4):688-94. PubMed ID: 9556069
[TBL] [Abstract][Full Text] [Related]
7. Phosphatidylinositol 3-kinase isoform-specific effects in airway mesenchymal cell function.
Moir LM; Trian T; Ge Q; Shepherd PR; Burgess JK; Oliver BG; Black JL
J Pharmacol Exp Ther; 2011 May; 337(2):557-66. PubMed ID: 21349933
[TBL] [Abstract][Full Text] [Related]
8. Theoretical studies on beta and delta isoform-specific binding mechanisms of phosphoinositide 3-kinase inhibitors.
Zhu J; Pan P; Li Y; Wang M; Li D; Cao B; Mao X; Hou T
Mol Biosyst; 2014 Mar; 10(3):454-66. PubMed ID: 24336903
[TBL] [Abstract][Full Text] [Related]
9. Phosphatidylinositol 3-kinase β and δ isoforms play key roles in metastasis of prostate cancer DU145 cells.
Zhang Z; Liu J; Wang Y; Tan X; Zhao W; Xing X; Qiu Y; Wang R; Jin M; Fan G; Zhang P; Zhong Y; Kong D
FASEB J; 2018 Nov; 32(11):5967-5975. PubMed ID: 29792732
[TBL] [Abstract][Full Text] [Related]
10. Wortmannin, a potent inhibitor of phosphatidylinositol 3-kinase, inhibits osteoclastic bone resorption in vitro.
Hall TJ; Jeker H; Schaueblin M
Calcif Tissue Int; 1995 Apr; 56(4):336-8. PubMed ID: 7767847
[TBL] [Abstract][Full Text] [Related]
11. Evidence for a role for the p110-alpha isoform of PI3K in skeletal function.
Grey A; Chaussade C; Empson V; Lin JM; Watson M; O'Sullivan S; Rewcastle G; Naot D; Cornish J; Shepherd P
Biochem Biophys Res Commun; 2010 Jan; 391(1):564-9. PubMed ID: 19931507
[TBL] [Abstract][Full Text] [Related]
12. Advantages of a selective beta-isoform phosphoinositide 3-kinase antagonist, an anti-thrombotic agent devoid of other cardiovascular actions in the rat.
Sturgeon SA; Jones C; Angus JA; Wright CE
Eur J Pharmacol; 2008 Jun; 587(1-3):209-15. PubMed ID: 18455722
[TBL] [Abstract][Full Text] [Related]
13. A pharmacological model reveals biased dependency on PI3K isoforms for tumor cell growth.
Wang X; Li JP; Yang Y; Ding J; Meng LH
Acta Pharmacol Sin; 2013 Sep; 34(9):1201-7. PubMed ID: 23892273
[TBL] [Abstract][Full Text] [Related]
14. The phosphoinositide 3-kinase isoform PI3Kβ regulates osteoclast-mediated bone resorption in humans and mice.
Győri D; Csete D; Benkő S; Kulkarni S; Mandl P; Dobó-Nagy C; Vanhaesebroeck B; Stephens L; Hawkins PT; Mócsai A
Arthritis Rheumatol; 2014 Aug; 66(8):2210-21. PubMed ID: 24719382
[TBL] [Abstract][Full Text] [Related]
15. Effects of wortmannin analogs on bone in vitro and in vivo.
Sato M; Bryant HU; Dodge JA; Davis H; Matter WF; Vlahos CJ
J Pharmacol Exp Ther; 1996 Apr; 277(1):543-50. PubMed ID: 8613966
[TBL] [Abstract][Full Text] [Related]
16. Regulation of CD38 expression in human airway smooth muscle cells: role of class I phosphatidylinositol 3 kinases.
Jude JA; Tirumurugaan KG; Kang BN; Panettieri RA; Walseth TF; Kannan MS
Am J Respir Cell Mol Biol; 2012 Oct; 47(4):427-35. PubMed ID: 22556157
[TBL] [Abstract][Full Text] [Related]
17. Calcium/calmodulin-dependent kinase activity is required for efficient induction of osteoclast differentiation and bone resorption by receptor activator of nuclear factor kappa B ligand (RANKL).
Ang ES; Zhang P; Steer JH; Tan JW; Yip K; Zheng MH; Joyce DA; Xu J
J Cell Physiol; 2007 Sep; 212(3):787-95. PubMed ID: 17477372
[TBL] [Abstract][Full Text] [Related]
18. Proviral integration site for Moloney murine leukemia virus 1, but not phosphatidylinositol-3 kinase, is essential in the antiapoptotic signaling cascade initiated by IL-5 in eosinophils.
Andina N; Didichenko S; Schmidt-Mende J; Dahinden CA; Simon HU
J Allergy Clin Immunol; 2009 Mar; 123(3):603-11. PubMed ID: 19152965
[TBL] [Abstract][Full Text] [Related]
19. The tyrosine kinase inhibitor GNF-2 suppresses osteoclast formation and activity.
Kim HJ; Yoon HJ; Choi JY; Lee IK; Kim SY
J Leukoc Biol; 2014 Feb; 95(2):337-45. PubMed ID: 24130113
[TBL] [Abstract][Full Text] [Related]
20. Phosphatidylinositol 3-kinase association with the osteoclast cytoskeleton, and its involvement in osteoclast attachment and spreading.
Lakkakorpi PT; Wesolowski G; Zimolo Z; Rodan GA; Rodan SB
Exp Cell Res; 1997 Dec; 237(2):296-306. PubMed ID: 9434625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
